Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder
The DOI matches its Crossref record.
Abstract
Objective Herein we provide the 2015 update for the Florida Best Practice Psychotherapeutic Medication Guidelines (FPG) for major depressive disorder (MDD). The FPG represent evidence-based decision support for practitioners providing care to adults with MDD. Participants The consensus meeting included representatives from the Florida Agency for Health Care Administration (FAHCA), advocacy members, academic experts in MDD, and multidisciplinary mental health clinicians, as well as health policy experts. The FAHCA provided funding support for the FPG. Evidence Evidence was limited to results from adequately powered, randomized, double-blind, placebo-controlled trials; in addition, pooled-, meta-, and network-analyses were included. Recommendations were based on consensus arrived at by the multistakeholder Florida Expert Panel. Articles selected were identified on the electronic search engine PubMed with the dates 2010 to present. The search terms were major depressive disorder, psychopharmacology, antidepressants, psychotherapy, neuromodulation, complementary alternative medicines, pooled-analysis, meta-analysis, and network-analysis. Bibliographies of the identified articles were manually searched for additional citations not identified in the original search. Consensus process A consensus meeting comprising all representatives took place on September 25-26, 2015, in Tampa, Florida. Guiding principles (eg, emphasis on the most rigorous evidence for efficacy, safety, and toler…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further drawbacks of existing TRD defi nitions are that they fail to take into consid eration the social, economic, anamnestic (e.g., adverse childhood experiences) and interpersonal factors which, alone or in combinations, are known to moderate antidepressant response 1,44,47,71,75- 81 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [47]
In the citing paper
“Mixed features are reported to be present in approximately 25% of persons with MDD and are associated with attenuated antidepressant response, although it remains to be determined whether they are a risk factor specifically for TRD 47,131 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [47]
Citations
Cites
Still being checked.
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationMcIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationAntidepressant Medications and Weight Change: A Narrative Review
Gill, H., Gill, B., El‐Halabi, S., Chen‐Li, D., Lipsitz, O., Rosenblat, J. D., Van Rheenen, T. E., Rodrigues, N. B., Mansur, R. B., Majeed, A., et al. (2020) · Obesity · doi:10.1002/oby.22969 · Cited by 193
Self-citationGuu, T.-W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., Freeman, M. P., Maes, M., Matsuoka, Y. J., Belmaker, R. H., et al. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000502652 · Cited by 191
Ross, E. L., Zivin, K., & Maixner, D. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0768 · Cited by 150
McIntyre, R. S., Rodrigues, N. B., Lee, Y., Lipsitz, O., Subramaniapillai, M., Gill, H., Nasri, F., Majeed, A., Lui, L. M. W., Senyk, O., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.088 · Cited by 110
Self-citationSaragoussi, D., Christensen, M. C., Hammer-Helmich, L., Rive, B., Touya, M., & Haro, J. M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159276 · Cited by 110
Neuropharmacological classification of antidepressant agents based on their mechanisms of action
Fasipe, O. (2018) · Archives of Medicine and Health Sciences · doi:10.4103/amhs.amhs_7_18 · Cited by 80
“These classes of antidepressants appear to enhance the synaptic availability of 5‐HT, norepinephrine, and/or dopamine.[2,3,7,8]”
BackgroundMultinational comparison of new antidepressant use in older adults: a cohort study
Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027663 · Cited by 76
Ragguett, R., Rong, C., Rosenblat, J. D., Ho, R., & McIntyre, R. S. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1459564 · Cited by 74
Self-citationDodd, S., Mitchell, P. B., Bauer, M., Yatham, L., Young, A. H., Kennedy, S. H., Williams, L., Suppes, T., Lopez Jaramillo, C., Trivedi, M. H., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1379609 · Cited by 68
Self-citationVerdolini, N., Hidalgo‐Mazzei, D., Murru, A., Pacchiarotti, I., Samalin, L., Young, A. H., Vieta, E., & Carvalho, A. F. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12896 · Cited by 67
McIntyre, R. S., Lipsitz, O., Rodrigues, N. B., Lee, Y., Cha, D. S., Vinberg, M., Lin, K., Malhi, G. S., Subramaniapillai, M., Kratiuk, K., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12941 · Cited by 66
Self-citationThe emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
Fasipe, O. J. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.01.001 · Cited by 62
The emerging role of psilocybin and MDMA in the treatment of mental illness
Gill, H., Gill, B., Chen-Li, D., El-Halabi, S., Rodrigues, N. B., Cha, D. S., Lipsitz, O., Lee, Y., Rosenblat, J. D., Majeed, A., et al. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1826931 · Cited by 61
Self-citationHu, Z., Ching, L. W., Hui-juan, L., Liang, Y., Zhiyu, W., Weiyang, H., Zhaoxiang, B., & Zhong, L. L. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-88263-y · Cited by 55
Ross, E. L., & Soeteman, D. I. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900625 · Cited by 51
Development and implementation of guidelines for the management of depression: a systematic review
Lee, Y., Brietzke, E., Cao, B., Chen, Y., Linnaranta, O., Mansur, R. B., Cortes, P., Kösters, M., Majeed, A., Tamura, J. K., et al. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.20.251405 · Cited by 45
Self-citationReal‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13284 · Cited by 40
Self-citationLipsitz, O., McIntyre, R., Rodrigues, N. B., Kaster, T., Cha, D., Brietzke, E., Gill, H., Nasri, F., Lin, K.-G., Subramaniapillai, M., et al. (2020) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110126 · Cited by 22
Self-citationFu, A. Z., Pesa, J. A., Lakey, S. L., & Benson, C. J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03895-2 · Cited by 30
Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
Shim, I. H., Bahk, W., Woo, Y. S., & Yoon, B.-H. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.4.376 · Cited by 30
Keeping up with the clinical advances: depression
Ragguett, R.-M., Tamura, J. K., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852919001159 · Cited by 27
Self-citationGiakoumatos, C. I., & Osser, D. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000197 · Cited by 27
Cariprazine for the treatment of bipolar depression: a review
Ragguett, R., & McIntyre, R. S. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1580571 · Cited by 26
Self-citationBartova, L., Fugger, G., Dold, M., Swoboda, M. M. M., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.028 · Cited by 25
Effectiveness of an alternative intervention in the treatment of depressive symptoms
Cardozo-Batista, L., & Tucci, A. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.060 · Cited by 24
Durgam, S., Kozauer, S. G., Earley, W. R., Chen, C., Huo, J., Lakkis, H. D., Stahl, S. M., & McIntyre, R. S. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001964 · Cited by 23
Self-citationFoster, A. E., & King, J. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190047 · Cited by 20
Bangalore, S., Shah, R., Pappadopulos, E. A., Deshpande, C. G., Shelbaya, A., Prieto, R., Stephens, J., & McIntyre, R. S. (2018) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcy023 · Cited by 20
Self-citationDiagnosing and Treating Patients With Mixed Features
Jain, R., Maletic, V., & McIntyre, R. S. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.su17009ah1c · Cited by 19
Self-citationMcIntyre, R. S., Prieto, R., Schepman, P., Yeh, Y.-C., Boucher, M., Shelbaya, A., Chambers, R., Gao, X., & Pappadopulos, E. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1652053 · Cited by 15
Self-citationGabriel, F. C., Stein, A. T., de Melo, D. O., Henrique Fontes-Mota, G. C., dos Santos, I. B., de Oliveira, A. F., Fráguas, R., & Ribeiro, E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-051918 · Cited by 15
Tamura, J. K., Harangi, D., Rodrigues, N. B., Mansur, R. B., Subramaniapillai, M., Johnson, D. E., Rosenblat, J. D., Lee, Y. L., Vincenzo, J. D. D., Ho, R., et al. (2024) · CNS Spectrums · doi:10.1017/s1092852924002293 · Cited by 13
Self-citationThe Mixed-Features Specifier of Major Depressive Disorder in DSM-5: Is It Practical?
Park, Y. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.11.10 · Cited by 13
McIntyre, R. S., Young, A. H., & Haddad, P. M. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318762911 · Cited by 12
Self-citationZainal, N. H., Bossarte, R. M., Gildea, S. M., Hwang, I. H., Kennedy, C. J., Liu, H., Leung, L. B., Luedtke, A. R., Marx, B. P., Petukhova, M. V., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02500-0 · Cited by 12
Christensen, M. C., Sluth, L. B., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.034 · Cited by 11
Self-citationSanadgol, N., Feriz, A. M., Lisboa, S. F. D. S., & Joca, S. R. L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122025 · Cited by 11
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Rognoni, C., Falivena, C., Costa, F., & Armeni, P. (2023) · PharmacoEconomics · doi:10.1007/s40273-022-01220-z · Cited by 10
Adverse effects of electroconvulsive therapy
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014995 · Cited by 9
Fasipe, O. J., & Ogunboye, I. (2024) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqae017 · Cited by 9
Rosenblat, J. D., Simon, G. E., Sachs, G. S., Deetz, I., Doederlein, A., DePeralta, D., Dean, M. M., & McIntyre, R. S. (2018) · Annals of Clinical Psychiatry · doi:10.1177/104012371803000407 · Cited by 8
Self-citationThe Unmet Needs for Major Depressive Disorder
McIntyre, R. S., & Gill, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_3 · Cited by 8
Self-citationReal-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
Fancy, F., Rodrigues, N. B., Vincenzo, J. D. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021022 · Cited by 8
Self-citationEfficacy of levomilnacipran extended release in treating major depressive disorder
Ragguett, R., Yim, S. J., Ho, P. T., & McIntyre, R. S. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1410540 · Cited by 8
Self-citationFasipe, O. J. (2019) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_110_18 · Cited by 7
Electroconvulsive therapy for depression
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013843 · Cited by 7
Mineo, L., Rodolico, A., Concerto, C., Natale, A., Pennisi, M., Tusconi, M., Aguglia, A., Amerio, A., Serafini, G., Amore, M., et al. (2021) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017902117010331 · Cited by 7
Bossarte, R. M., Ross, E. L., Liu, H., Turner, B., Bryant, C., Zainal, N. H., Puac‐Polanco, V., Ziobrowski, H. N., Cui, R., Cipriani, A., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.082 · Cited by 6
Macnamara, C. L., Cvejic, E., Parker, G. B., Lloyd, A. R., Lee, G., Beilharz, J. E., & Vollmer-Conna, U. S. (2018) · Trials · doi:10.1186/s13063-018-2763-8 · Cited by 6
Cai, Q., Patel, C. A., Kim, E., Connolly, N., Tunceli, O., & Khoury, A. C. E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00913-w · Cited by 5
Jain, R. K., Laliberté, F., Germain, G., Mahendran, M., Higa, S., Harrington, A., & Parikh, M. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.8.896 · Cited by 4
Electroconvulsive therapy for preventing relapse and recurrence in people with depression
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015164 · Cited by 3
Xu, L., He, J., Yang, L., Du, D., Yang, F., Feng, L., Jin, Y., Li, C., & Yang, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07393-z · Cited by 3
Psychopharmacology Algorithms for Major Depressive Disorder: Current Status
Sanches, M., Quevedo, J., & Soares, J. C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_21 · Cited by 2
Gao, S., Chen, Y., Liu, J., Zhang, Q., Zhao, X., Liu, B., Zhang, Y., Li, L., & Wang, G. (2025) · Psychological Medicine · doi:10.1017/s0033291725101955 · Cited by 2
Gabriel, F. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2022.tde-14022023-162448
Algorithmen und Leitlinien zur Behandlung der akuten Depression: Eine Übersicht
Adli, M., Bschor, T., & Seemüller, F. (2018) · Nervenheilkunde · doi:10.1055/s-0038-1670569
Boskovic, D. H., Kapadia, S., Ardic, F. C., Eisenberg, D. F., Hickey, J., Rogerson, O., & Glen, F. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002140
Self and Hetero-Aggression: Clinical Implications in Bipolar Disorder and Mixed States
Verdolini, N. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The Atypical Antipsychotics as a New Generation Class of Antidepressants in Clinical Practice
Ibiyemi-Fasipe, O., & Fasipe, O. J. (2019) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_259_18
Cardozo-Batista, L., & Tucci, A. M. (2024) · Aracê. · doi:10.56238/arev6n2-188
Antidepressant Class and Concurrent rTMS Outcomes in MDD: a Systematic Review and Meta-Analysis
Zaidi, A. (2025) · TSpace (University of Toronto)
Ketamine for Bipolar Depression
Fancy, F. (2024) · TSpace (University of Toronto)
Lee, Y. (2021) · TSpace (University of Toronto)
Gill, H. (2025) · TSpace (University of Toronto)
Sukeltų emocinių būsenų poveikis moterų reakcijai į maisto užuominas
Stanytė, A. (2019) · Lithuanian University of Health Sciences · doi:10.15388/proceedings.2020.1
Depresión y homeopatía: revisión de la literatura y reporte de un caso
Garzón, L. D. P. (2018) · Repositorio Institucional UN - Biblioteca Digital
Metadata
- Authors
- McIntyre, R. S., Suppes, T., Tandon, R., & Ostacher, M.
- Affiliations
- University Health Network (CA)
- VA Palo Alto Health Care System (US)
- University of Florida Health (US)
- Corresponding author
- McIntyre, Roger S.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2017-06-28
- Volume
- 78
- Issue
- 06
- Pages
- 703-713
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2729558697
- Cited by
- 61
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 11 · 2019: 10 · 2018: 13 · 2017: 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- major depressive disorder, antidepressants, psychotherapy, neuromodulation, complementary and alternative medicine, pharmacogenomics, mixed features, measurement-based care, suicide risk assessment
- MeSH terms
- Adult, Antidepressive Agents, Consensus Statements as Topic, Major Depressive Disorder, Florida, Humans, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.